Systemic lupus erythematosus complicated with cardiovascular disease

Ke-Qu Lu¹, Zhen-Zhen Zhu¹, Si-Ru Wei¹, Hua-Song Zeng², Han-You Mo^{3

4}

Affiliations

¹ Department of Rheumatology, Guilin Medical University, Guilin, China.
² Department of Pediatric Allergy, Immunology & Rheumatology, Women and Children's Medical Center, Guanzhou Medical University, Center and South National Pediatric Medical Center, Guanzhou, China.
³ Department of Rheumatology, The Affiliated Hospital of Guilin Medical University, Guilin, China.
⁴ Department of Rheumatology and Immunology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Editorial

Ke-Qu Lu et al. Int J Rheum Dis. 2023 Aug.

. 2023 Aug;26(8):1429-1431.

doi: 10.1111/1756-185X.14741. Epub 2023 Jul 23.

Ke-Qu Lu¹, Zhen-Zhen Zhu¹, Si-Ru Wei¹, Hua-Song Zeng², Han-You Mo^{3

4}

¹ Department of Rheumatology, Guilin Medical University, Guilin, China.
² Department of Pediatric Allergy, Immunology & Rheumatology, Women and Children's Medical Center, Guanzhou Medical University, Center and South National Pediatric Medical Center, Guanzhou, China.
³ Department of Rheumatology, The Affiliated Hospital of Guilin Medical University, Guilin, China.
⁴ Department of Rheumatology and Immunology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

No abstract available

References

1. Ahn GY, Lee J, Won S, et al. Identifying damage clusters in patients with systemic lupus erythematosus. Int J Rheum Dis. 2020;23(1):84-91. doi:10.1111/1756-185x.13745
1. Li M, Wang Y, Zhao J, et al. Chinese SLE treatment and research group (CSTAR) registry 2009-2019: major clinical characteristics of Chinese patients with systemic lupus erythematosus. Rheumatol Immunol Res. 2021;2(1):43-47. doi:10.2478/rir-2021-0001
1. Etchegaray-Morales I, Mendoza-Pinto C, Munguia-Realpozo P, et al. Systemic lupus erythematosus, a leading cause of death in young Mexican females: a nationwide population-based study, 2000-2020. Rheumatol Int. 2022;42(10):1715-1720. doi:10.1007/s00296-022-05154-9
1. Ugarte-Gil MF, Alarcon GS, Izadi Z, et al. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 global rheumatology Alliance. Ann Rheum Dis. 2022;81(7):970-978. doi:10.1136/annrheumdis-2021-221636
1. Ci W, Zhao J, Qi W, et al. Characteristics and Risk Factors of Severe Coronary Artery Disease in Systemic Lupus Erythematosus: A Multicenter, Chinese Rheumatism Date Center database study. Int J Rheum Dis. 2022;25(10):1186-1195. doi:10.1111/1756-185x.14402